|
DGTR reschedules hearing on anti-dumping of chemical intermediate MPDA from September 21 to 29
|
|
Shardul Nautiyal, Mumbai
September 27 , 2023
|
|
|
The Directorate General of Trade Remedies (DGTR) has rescheduled the oral hearing on anti-dumping of Chinese imports of chemical intermediate meta phenylene diamine (MPDA) widely used in medical applications from September 21 to September 29, 2023 in its New Delhi office.
The oral hearing of the sunset review investigation on anti-dumping of chemical intermediate MPDA was scheduled to be held on September 21, 2023 from 2.30 pm to 4:30 pm in hybrid mode i.e., both through digital video conferencing (DVC) and physically.
Sunset review investigation of anti-dumping duty on import of MPDA originating in or exported from China, was initiated on June 30, 2023 under the Customs Tariff (Identification, Assessment and Collection of Anti-dumping duty on Dumped Articles and for Determination of Injury) Rules, 1995 (AD Rules).
Aarti Industry Ltd., Mumbai had filed an application before the DGTR, in accordance with the Customs Tariff Act, 1975 for alleged dumping of MPDA originating in or exported from China and had requested for initiation of anti- dumping investigation and levy of anti-dumping measures. DGTR had initiated the investigation through a notification on June 19, 2012.
The applicant has claimed that the subject goods, which are being dumped into India, are identical to the goods produced by the domestic industry. There are no known differences either in the technical specifications, quality, functions or end-uses of the dumped imports and the domestically produced subject goods. The two are technically and commercially substitutable and hence should be treated as ‘like article’ under the AD Rules. Thus, the subject goods produced by the Applicant are being treated as an article to the product under consideration imported from the subject country within the meaning of the AD Rules for the purpose of this investigation.
The application has been filed by Aarti Industry Ltd., Mumbai on behalf of the domestic industry. It has been claimed that Aarti Industry Ltd. is the sole producer of the subject goods in India. The application, therefore, satisfies the requirements of Rule 2(b) and Rule 5(3) of the AD Rules. Thus, the Authority has determined that the application satisfies the requirements of Rule 2(b) and Rule 5(3) of the AD Rules and the Applicant is being treated as ‘domestic industry’ within the meaning of Rule 2(b) of the AD Rules.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|